Epicardial Mitral Repair Trial - ENRAPT-MR (ENRAPT-MR)
ENRAPT-MR Trial: Epicardial Mitral Repair
Sponsor: Medical Metrics Diagnostics, Inc
Listed as NCT03864848, this NA trial focuses on Mitral Regurgitation and remains ongoing. Sponsored by Medical Metrics Diagnostics, Inc, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Feb 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Feb 2023 — Jul 2024 [monthly]
Recruiting NA
-
May 2022 — Feb 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Apr 2022 — May 2022 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
-
Dec 2021 — Apr 2022 [monthly]
Withheld
-
Mar 2021 — Dec 2021 [monthly]
Withheld
-
Jan 2021 — Mar 2021 [monthly]
Withheld
-
Jun 2020 — Jan 2021 [monthly]
Withheld
-
Apr 2019 — Jun 2020 [monthly]
Withheld
First recorded
Dec 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical Metrics Diagnostics, Inc
- Meditrial Europe Ltd.
- Mitre Medical Corp.
For direct contact, visit the study record on ClinicalTrials.gov .